IPSC haplobanks store induced pluripotent stem cell lines matched to common HLA types, enabling ready-to-use, immune-compatible cell therapies. They support scalable manufacturing, reduce rejection risks, and accelerate the development of regenerative and personalized medicine across diverse patient populations. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/